Literature DB >> 15192618

Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.

Pat Mahachoklertwattana1, Soamarat Vilaiyuk, Suradej Hongeng, Chusak Okascharoen.   

Abstract

OBJECTIVE: To evaluate adrenal function in children with acute lymphoblastic leukemia (ALL) after induction therapy with corticosteroid and other cytotoxic agents. Study design Children with ALL (N=24) were treated with prednisolone (40 mg/m(2) per day) for 28 days during the induction phase followed by 1 week of oral dexamethasone every 4 weeks. A low-dose (1 microg) adrenocorticotropin (ACTH) test was performed 2 weeks after discontinuation of prednisolone; it was repeated 2 weeks later and then every 4 weeks in patients with adrenal suppression until normal response was achieved.
RESULTS: Adrenal suppression was found in 46% of patients at 2 weeks after discontinuation of prednisolone; it persisted in 38%, 29%, and 13% of patients through 4 weeks, 8 weeks, and 20 weeks, respectively. Adrenal suppression appeared to last significantly longer in children aged >or=5 years than in children aged <5 years. Four children developed febrile neutropenia; all belonged to the adrenal suppressed group and were unable to mount an adequate adrenal response to the stress.
CONCLUSIONS: About 50% of children with ALL developed adrenal suppression 2 weeks after a 4-week induction therapy with prednisolone. The suppression could persist through 20 weeks and may hinder an adequate adrenal response during acute febrile illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192618     DOI: 10.1016/j.jpeds.2004.03.033

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Recovery of steroid induced adrenal insufficiency.

Authors:  Areej K Younes; Noor K Younes
Journal:  Transl Pediatr       Date:  2017-10

2.  Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.

Authors:  Ruben D de Ruiter; M Suzanne Gordijn; Reinoud J B J Gemke; Cor van den Bos; Marc B Bierings; Joost Rotteveel; Jan W Koper; Elisabeth F C van Rossum; Gertjan L Kaspers
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease.

Authors:  Maya Lodish; Somya Verma Dunn; Ninet Sinaii; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

Review 4.  Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

Authors:  Niki Rensen; Reinoud Jbj Gemke; Elvira C van Dalen; Joost Rotteveel; Gertjan Jl Kaspers
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

5.  Emotional regulation and adjustment to childhood cancer: role of the biological, psychological and social regulators on pediatric oncology adjustment.

Authors:  Manijeh Firoozi; Mohammad Ali Besharat; Eshagh Rahimian Boogar
Journal:  Iran J Cancer Prev       Date:  2013

Review 6.  Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children.

Authors:  Fahad Aljebab; Imti Choonara; Sharon Conroy
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.